Margarida Azevedo, MSc,  —

Treatment with TNF inhibitors eased disease activity and improved physical function for people with axial spondyloarthritis (axSpA), according to a real-world study from Italy. The extent of functional improvement correlates with both lower disease activity and shorter disease duration. The study, “Improvement of Function and…

Blood levels of the protein S100A4 are elevated in patients with axial spondyloarthritis (axSpA), especially at early stages of the disease, a study found. The excessive spinal bone formation that occurs over time seems to be marked by a reduction in the protein’s levels, suggesting its implication in…